Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Conditions:   Breast Cancer;   Endocrine Therapy;   CDK4/6 Inhibitors;   Subsequent Treatment Intervention:   Drug: Different treatment regimens following progression on CDK4/6 inhibitors. Sponsor:   Hunan Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials